BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 23307318)

  • 1. Enhanced production of CTGF and IL-11 from highly metastatic hepatoma cells under hypoxic conditions: an implication of hepatocellular carcinoma metastasis to bone.
    Gao YB; Xiang ZL; Zhou LY; Wu ZF; Fan J; Zeng HY; Zeng ZC
    J Cancer Res Clin Oncol; 2013 Apr; 139(4):669-79. PubMed ID: 23307318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene expression profiling of fixed tissues identified hypoxia-inducible factor-1α, VEGF, and matrix metalloproteinase-2 as biomarkers of lymph node metastasis in hepatocellular carcinoma.
    Xiang ZL; Zeng ZC; Fan J; Tang ZY; Zeng HY; Gao DM
    Clin Cancer Res; 2011 Aug; 17(16):5463-72. PubMed ID: 21712445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential prognostic biomarkers for bone metastasis from hepatocellular carcinoma.
    Xiang ZL; Zeng ZC; Tang ZY; Fan J; He J; Zeng HY; Zhu XD
    Oncologist; 2011; 16(7):1028-39. PubMed ID: 21665914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of WWP1 promotes tumorigenesis and predicts unfavorable prognosis in patients with hepatocellular carcinoma.
    Zhang XF; Chao J; Pan QZ; Pan K; Weng DS; Wang QJ; Zhao JJ; He J; Liu Q; Jiang SS; Chen CL; Zhang HX; Xia JC
    Oncotarget; 2015 Dec; 6(38):40920-33. PubMed ID: 26506518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mild chronic hypoxia-induced HIF-2α interacts with c-MYC through competition with HIF-1α to induce hepatocellular carcinoma cell proliferation.
    Mu H; Yu G; Li H; Wang M; Cui Y; Zhang T; Song T; Liu C
    Cell Oncol (Dordr); 2021 Oct; 44(5):1151-1166. PubMed ID: 34339013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Curcumin Suppresses Hepatic Stellate Cell-Induced Hepatocarcinoma Angiogenesis and Invasion through Downregulating CTGF.
    Shao S; Duan W; Xu Q; Li X; Han L; Li W; Zhang D; Wang Z; Lei J
    Oxid Med Cell Longev; 2019; 2019():8148510. PubMed ID: 30800209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ELK3 promotes the migration and invasion of liver cancer stem cells by targeting HIF-1α.
    Lee JH; Hur W; Hong SW; Kim JH; Kim SM; Lee EB; Yoon SK
    Oncol Rep; 2017 Feb; 37(2):813-822. PubMed ID: 27959451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of connective tissue growth factor and interleukin-11 in intratumoral tissue is associated with poor survival after curative resection of hepatocellular carcinoma.
    Xiang ZL; Zeng ZC; Fan J; Tang ZY; Zeng HY
    Mol Biol Rep; 2012 May; 39(5):6001-6. PubMed ID: 22205539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Artemin is hypoxia responsive and promotes oncogenicity and increased tumor initiating capacity in hepatocellular carcinoma.
    Zhang M; Zhang W; Wu Z; Liu S; Sun L; Zhong Y; Zhang X; Kong X; Qian P; Zhang H; Lobie PE; Zhu T
    Oncotarget; 2016 Jan; 7(3):3267-82. PubMed ID: 26675549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of hypoxia-inducible factor-1α silencing on the proliferation of CBRH-7919 hepatoma cells.
    Xu LF; Ni JY; Sun HL; Chen YT; Wu YD
    World J Gastroenterol; 2013 Mar; 19(11):1749-59. PubMed ID: 23555163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hint1 suppresses migration and invasion of hepatocellular carcinoma cells in vitro by modulating girdin activity.
    Wu XS; Bao TH; Ke Y; Sun DY; Shi ZT; Tang HR; Wang L
    Tumour Biol; 2016 Nov; 37(11):14711-14719. PubMed ID: 27623945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of connective tissue growth factor overexpression decreases growth of hepatocellular carcinoma cells in vitro and in vivo.
    Jia XQ; Cheng HQ; Li H; Zhu Y; Li YH; Feng ZQ; Zhang JP
    Chin Med J (Engl); 2011 Nov; 124(22):3794-9. PubMed ID: 22340243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long non-coding RNA UBE2CP3 enhances HCC cell secretion of VEGFA and promotes angiogenesis by activating ERK1/2/HIF-1α/VEGFA signalling in hepatocellular carcinoma.
    Lin J; Cao S; Wang Y; Hu Y; Liu H; Li J; Chen J; Li P; Liu J; Wang Q; Zheng L
    J Exp Clin Cancer Res; 2018 Jun; 37(1):113. PubMed ID: 29866133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The TNF-α/ROS/HIF-1-induced upregulation of FoxMI expression promotes HCC proliferation and resistance to apoptosis.
    Xia L; Mo P; Huang W; Zhang L; Wang Y; Zhu H; Tian D; Liu J; Chen Z; Zhang Y; Chen Z; Hu H; Fan D; Nie Y; Wu K
    Carcinogenesis; 2012 Nov; 33(11):2250-9. PubMed ID: 22831955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-338-3p inhibits hepatocarcinoma cells and sensitizes these cells to sorafenib by targeting hypoxia-induced factor 1α.
    Xu H; Zhao L; Fang Q; Sun J; Zhang S; Zhan C; Liu S; Zhang Y
    PLoS One; 2014; 9(12):e115565. PubMed ID: 25531114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Twist may be associated with invasion and metastasis of hypoxic NSCLC cells.
    Wei L; Sun JJ; Cui YC; Jiang SL; Wang XW; Lv LY; Xie L; Song XR
    Tumour Biol; 2016 Jul; 37(7):9979-87. PubMed ID: 26819207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ack1 overexpression promotes metastasis and indicates poor prognosis of hepatocellular carcinoma.
    Lei X; Li YF; Chen GD; Ou DP; Qiu XX; Zuo CH; Yang LY
    Oncotarget; 2015 Dec; 6(38):40622-41. PubMed ID: 26536663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Silencing of hypoxia-inducible factor-1β induces anti-tumor effects in hepatoma cell lines under tumor hypoxia.
    Choi SH; Chung AR; Kang W; Park JY; Lee MS; Hwang SW; Kim DY; Kim SU; Ahn SH; Kim S; Han KH
    PLoS One; 2014; 9(7):e103304. PubMed ID: 25068796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PTEN inhibits the migration and invasion of HepG2 cells by coordinately decreasing MMP expression via the PI3K/Akt pathway.
    Tian T; Nan KJ; Guo H; Wang WJ; Ruan ZP; Wang SH; Liang X; Lu CX
    Oncol Rep; 2010 Jun; 23(6):1593-600. PubMed ID: 20428814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of Hes-1, a downstream target of notch signaling in hepatocellular carcinoma.
    Zou JH; Xue TC; Sun C; Li Y; Liu BB; Sun RX; Chen J; Ren ZG; Ye SL
    Asian Pac J Cancer Prev; 2015; 16(9):3811-6. PubMed ID: 25987042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.